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   Abstract 
The sigma1 receptor (Sigma1) is an integral endoplasmic reticulum (ER) membrane 
protein that is highly expressed in several cancer cell types. We have shown that certain 
Sigma1 selective small molecule ligands disrupt ER protein homeostasis in prostate, 
liver, pancreas, and several breast cancer cell lines. However, as Sigma1 has no known 
intrinsic signaling activity, the mechanism of action of this ligand-mediated ER stress 
remains unclear. We hypothesize that identification of Sigma1-associated proteins will 
provide insight into its role in ER protein homeostasis as well as elucidate the mechanism 
of action of Sigma1 selective ligands. Thus, we have developed an affinity-purification 
method that will enable us to isolate and characterize Sigma1 and its associated proteins 
as well as Sigma1 protein complexes from several tumor cell lines. Consistent with our 
data demonstrating that Sigma1 ligands modulate ER protein homeostasis, these proteins 
are known to function in ER protein processing, transport, or degradation. Using this 
approach, we have identified a direct physical association of Sigma1 with the protein 
VCP (valosin containing protein), and treatment with a Sigma1-selective small molecule 
ligand results in dissociation of VCP from Sigma1. We find that treatment with this 
Sigma1 ligand mediates the reversible sequestration of ubiquitinated ER proteins into 
autophagosomes, and this ligand mediated ubiquitin-selective autophagy is Sigma1 
dependent. This effect correlates with the subcellular co-localization of VCP, 
ubiquitinated proteins, as well as known components involved in the formation and 
assembly of autophagosomes. This thesis proposes that Sigma1 associates with VCP to 
maintain proper ER protein processing, and that Sigma1-selective ligands can be used to 
modulate this association.  
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Chapter 1: Introduction 
 
The sigma receptor was initially considered an opioid receptor when it was first 
discovered in 1976 due to its affinity to opiate ligands[1-3] .  It was used to study the 
effects of antipsychotic drugs by various groups in the decade following. However, the 
notion of it being an opioid receptor was then challenged and refuted when it turned out 
to have no sensitivity to a common opioid receptor antagonist, naloxone [2, 4]. In the 
1990s, it was implicated in having functions related to the modulation of ion channels, 
and has been studied extensively as a possible target for the regulation of potassium 
channels in neurodegenerative diseases [3]. We find in tumor cells, as that sigma 
receptors are primarily found within the endoplasmic reticulum (ER). However, cellular 
function and physiological role remain unclear. 
There are two pharmacologically defined subtypes: Sigma1 and Sigma2[4]. Sigma1 
was cloned from various sources including rat guinea pig liver, rat brain, and human 
placenta, and Sigma2 has yet to be cloned [2, 5, 6]. Although the topology of Sigma1 is 
fairly established, its mechanism of action and structure-activity-relationships are still 
unclear, as it is implicated in a variety of diseases including from cancer and 
neurodegeneration [4]. It is an integral ER membrane protein that has a molecular weight 
of 26 kilodaltons (kDa) and comprises 223 amino acids long. It has two helical, 
transmembrane regions and a relatively long carboxy terminal tail. Sigma1 does not have 
any known endogenous ligands, nor does it have any intrinsic signaling activity leading 
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to the question whether it actually is a receptor [4, 7]. Also, as Sigma1 shares no 
homology with any other mammalian protein, it is a very unique protein to study. 
We hypothesize that Sigma1 functions primarily via associations with other proteins, 
and that identifying these associations will further elucidate Sigma1’s cellular function. 
Preliminary data from our lab identified that most of the functions of the proteins shown 
to associate with Sigma1 had primary roles in ER protein synthesis, processing, and 
degradation. A common stress-relieving mechanism within these cells is the degradation 
of misfolded proteins that cause ER stress [8]. Degradation occurs through the ubiquitin 
proteasome system, in which misfolded proteins that cause ER stress are tagged with the 
protein, ubiquitin  Maintenance of ER protein homeostasis through the unfolded protein 
response  (UPR)  relies on the timely convergence of multiple pathways that detect 
homeostatic protein concentration thresholds and control the ebb-and-flow of ER proteins 
[9]. In cases where UPR is not sufficient to alleviate the overwhelming levels of ER 
stress, a secondary survival response, autophagy is activated [10] 
Autophagy is a bulk cellular degradation mechanism that works by sequestering 
misfolded protein aggregates into membrane bound vesicles called autophagosomes. It is 
a process that occurs when cells are placed under conditions of ligand-induced stress or 
even nutrient starvation [11, 12]. These autophagosomes can fuse with lysosomes to form 
structures called autolysosomes, and the complete degradation of these sequestered 
components is known as autophagic flux. Autophagy can serve as a cyto-protective, 
survival mechanism, by which cells can maintain and restore homeostasis.  Inhibition of 
autophagy has shown to facilitate apoptosis in the context of neurodegenerative diseases.  
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Light chain 3 (LC3) is a protein that is biomarker for autophagosome formation. The 
lipid conjugated form of LC3, LC3 II is induced when autophagosomes are formed [13]. 
These autophagosomes are characterized by vesicular clusters or punctae that localize to 
particular locations within the cells. Another biomarker for autophagosome formation is 
p62/SQSTM1, an adaptor protein with an LC3 binding site that aids in the sequestration 
of cytotoxic components including organelles and macromolecules into the 
autophagosomes[12, 14].  
Valosin containing protein (VCP or p97) is a highly conserved protein that is 
assembled as a homo-hexameric ring, each 97kDa in molecular weight. It belongs to the 
class of AAA (ATPase that is associated with diverse cellular activities) [15-18]. 
Hydrolysis of ATP can lead to structural changes in VCP and drive VCP function[19].  
VCP has been implicated in various protein processing functions including: the 
degradation of misfolded proteins, Golgi membrane reassembly, membrane transport as a 
chaperone, and even autophagosome maturation. It has shown to associate with a 
multitude of proteins, but most commonly to poly-ubiquitinated proteins in the context of 
neurodegenerative diseases [18]. VCP has also been well characterized in its functions of 
transporting ubiquitinated proteins to the 26S proteasome for degradation, and when VCP 
is not functioning, the UPS is inhibited, resulting in an accumulation of ubiquitinated 
proteins [18]. As such, VCP is an established player in ubiquitin-mediated degradation of 
misfolded proteins [15, 17, 18, 20].  
However, as mentioned prior, when UPR is insufficient to cope with extreme levels 
of ER stress, autophagy is activated as a secondary survival response. VCP has been 
implicated in various functions during this process as well. VCP knockdown or dominant 
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negative VCP can induce the accumulation of autophagic vesicles, and impair 
autophagosome maturation [17].  Mutant forms of VCP have shown to result in defective 
autophagosome maturation. In disorders such as inclusion body myopathy, Paget’s 
disease of the bone, and fronto-temporal lobar degeneration, ubiquitinated inclusions 
have been key for the furthering the development of the diseases [15].  
Data previously obtained from our lab indicates that Sigma1 ligand induce ER stress, 
indicated by the induction of ubiquitiated proteins after treatment with the ligand. As a 
result of this ER stress, UPR markers were induced as well.  In addition, treatment with 
the same ligand had shown an accumulation of LC3-punctae, demonstrating 
autophagosome formation. As mentioned prior, VCP plays key roles in mitigating the 
effects of ER stress by its involvement in the degradation of misfolded proteins through 
the proteasome and its functions in autophagy. We hypothesized that there is not only a 
functional interaction between VCP and Sigma1, but a physical association. And that 
treatment with a specific Sigma1 ligand could potentially modulate this association 
resulting in the various downstream phenotypes. 
Our experimental approach to address this hypothesis was to confirm an association 
between Sigma1 and VCP by using a modified affinity-purification technique and 
immunoblotting. In addition, we explored the role of Sigma1 in ubiquitin-selective 
autophagy.  
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Chapter 2: Materials and Methods 
 
Nickel NTA: 
Equipment:  
 Refrigerated table-top centrifuge (Beckman Coulter-Allegra 6 E1798) 
 Refrigerated centrifuge: Eppendorf 5417R 
 Un-refrigerated centrifuge:  Eppendorf- 5424 
 End-over-end rotator (VWR- Multimix 120V) 
MDA-MB-468 breast cancer adenocarcinoma cells containing Sigma1 were stably 
transfected with an HA and His dual tagged Sigma1. This ectopic expression of Sigma1-
HA-His only exhibited characteristics similar to endogenous Sigma1 found in parental 
cells. Three or more of the His tags bind to the nickel nitriloacetic acid-agarose (Ni-
NTA—Qiagen R110-22-40- 42/43) complex with high affinity, enabling us to isolate 
Sigma1 and the proteins it associates with in a relatively high yield. After eluting Sigma1 
and its associating proteins off the resin using varying concentrations of competing 
imidazole buffer, we confirmed the identities of the proteins that Sigma1 interacts with 
by immunoblotting.  
Cells expressing Sigma1-HA-His were seeded on 10cm plates in culture with DMEM 
medium containing 10% fetal bovine serum and 1% Penicilin-Streptomycin 24 hours 
prior to treatment with the drug (Ligand- 1-(4-Iodophenyl)-3-(2-adamantyl) guanidine—
TOCRIS). Control samples were treated with a solvent vehicle, DMSO. Drug treatment 
occurred for 16 hours at a concentration of 10µM. The cells on a generally fully 
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confluent plate were then physically harvested in PBS using a scraper. They were then 
spun at 1100 RCF for 7 minutes in a refrigerated centrifuge. After discarding the PBS, 
the cells were then lysed twenty times  in a detergent buffer based of 0.5% NP-40 (Pierce 
– 28324), 40mM Hepes (pH 7.6), 150mM NaCl, 10% glycerol, 100µM HALT protease 
inhibitor and 100µM HALT phosphatase inhibitor. The volume of the lysis buffer was 
dependent on the number of cells harvested. The cell lysates were then rotated on an end-
over-end rotator at 4
0
C for thirty minutes, then centrifuged at 21,000 RCF for fifteen 
minutes, and the insoluble membrane components were removed. The whole cell lysate 
supernatants were then added onto washed Nickel resin-agarose beads and bound for 
ninety minutes on the end-over-end rotator at 4
0
C. 20mM imidazole of the final volume 
was added in the binding reaction to prevent non-specific binding onto the Nickel resin 
beads. Samples were then centrifuged for 2600 RCF in the refrigerated centrifuge for 2 
minutes to remove the flow thru from the Nickel resin beads. Samples were then washed 
with the lysis buffer three times to again remove the non-specific components. A 
sequential, step gradient with varying concentrations (200, 400, 500mM) of imidazole in 
lysis buffer was used to elute Sigma1-HA-His and its associated proteins. The primary 
goal with these experiments was to remove as much of the nonspecific binding as 
possible, while still maintaining many of the associations that we intended to confirm.  
 
Biochemical subcellular fractionation 
Equipment:  
 Refrigerated table-top centrifuge (Beckman Coulter-Allegra 6 E1798) 
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 Refrigerated centrifuge: Eppendorf 5417R 
 Un-refrigerated centrifuge:  Eppendorf- 5424 
 Refrigerated ultracentrifuge (Beckman Optima Series TLX-IM-3) 
 End-over-end rotator (VWR- Multimix 120V) 
 Beckman Rotor (Fixed angle TLA 100.4) 
 Beckman OptiSeal tubes (361621) 
 Beckman Spacers for OptiSeal tubes (361676) 
 Balch homogenizer and 12µm clearance ball bearing 
One 10cm plate of cells was seeded 24 hours prior to drug treatment. At 
approximately 50% confluency, the cells were then treated for 16 hours with Ligand or 
DMSO. The plates were nearly fully confluent prior to harvesting. The cells were scraped 
off using a scraper in PBS, and centrifuged in a refrigerated, table top centrifuge at 1000 
rcf for 7 minutes. After removing the PBS, the cells were then resuspended in 
homogenizing buffer (containing: 250mM sucrose, 25mM tris, 50mM NaCl, 1mM 
EDTA, with 100µM HALT phosphatase and protease inhibitors). Volume of the 
homogenizing buffer was dependent on the size of the cell pellet. After resuspension, the 
samples were lysed physically by passing through the 12µm clearance ball bearing within 
the Balch homogenizer twelve times. The nuclear components were separated by 
centrifuging the samples for fifteen minutes at 1000 RCF in a refrigerated centrifuge. The 
post-nuclear supernatant was then loaded onto a discontinuous, density-based gradient of 
OptiPrep Density Gradient Medium (Sigma-Aldrich) in the OptiSeal ultracentrifuge 
tubes. The Optiprep medium was diluted in 25mM Tris and 1mM EDTA homogenizing 
buffer diluent, and then loaded at concentrations of 1x 50%, 2x 30%, and 1x10%. 
10 
 
Following the gradients, the post-nuclear supernatant was then loaded and further diluted 
with the homogenizing buffer to fill the ultracentrifuge tube. The tubes were then spun in 
the fixed angle rotor for 19 hours at 4
0
C at 30,000 rpm. Fourteen 300µL fractions were 
then collected from the bottom of the tube and loaded onto western blots.  
Western blotting 
Equipment:  
 Gel apparatus (Invitrogen) 
 Invitrogen 4-12% Tris-Glycine gel 
 PVDF membrane 
 Wet gel transfer apparatus 
 3M Whatman paper 
 Alpha Innotech gel imager 
Antibodies used for western blots were for the proteins: HA (Santa Cruz 
Biotechnlogies), VCP (Cell Signaling Technloogies and Santa Cruz Biotechnlogies), p62 
(Santa Cruz Biotechnlogies), Ubiquitin (Cell Signaling Technloogies), and Sigma1 
(purified rabbit, polyclonal generated by Kim et al). Samples were processed using 
Laemmli buffer containing SDS, NaCl, and bromophenol blue. They were reduced and 
denatured using 100mM dithiothreitol and % w/v β-mercaptoethanol. Blots were blocked 
with 5% blotting grade milk and washed in 20mM Tris-buffered saline with 0.1% tween.  
Confocal Microscopy 
Equipment:  
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 Dual chamber slides (Labtek 154461) 
 Zeiss LSM 510 inverted confocal microscope 
MDA 468 cells that were stably transfected with GFP-LC3 were seeded onto chamber 
slides in complete medium (DMEM, 10% FBS, 1%Pnicillin/Streptomycin coctail). 24 
hours after seeding, the cells were then treated with 10µM of either Sigma1 ligand or 
DMSO. Cells were then fixed on the slide using 4% formaldehyde in PBS for 15 minutes. 
Cells were then unmasked using a low pH, citrate based, antigen-unmasking solution 
(Vector H-3300) in a 95
0
C water bath for ten minutes. The side walls of the chamber 
slides were removed and the sides were covered with a liquid repellent (Liquid blocker 
Super PAP PEN), and the slides were then blocked in a blocking solution containing 
0.1% bovine serum albumin, 0.3% Triton X-100 in PBS for 30 minutes at room 
temperature. They were then treated with a primary antibody (same as ones used for 
Western Blot) at a concentration of 1:1000 overnight at 4˚C. After thorough washing with 
PBS, the slides were then incubated with either with Alexa Fluor 594nm goat anti-mouse 
secondary or Alexa Fluor 647nm goat anti-rabbit secondary antibody at room 
temperature for one hour. After washing with PBS once again, cover slips were mounted 
onto the slides with Vectashield mounting medium and DAPI nuclear stain. The images 
were captured using the Zeiss LSM 510 inverted confocal microscope with an objective 
63x lens. The optimal images were obtained after adjusting the transmission and pinhole 
on the microscope to the proper settings. In addition, colocalization was confirmed by 
obtaining three dimensional, z-slices of the cells at 1µm intervals. Without confocal 
microscopy, we could not conclusively establish that any two proteins interacted, as 
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conventional light microscopes only provided a top view of the cells, when they are in 
fact three dimensional. 
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    Chapter 3: Results 
 
 
Sigma1 physically associates with VCP and it is possible to modulate the association 
with a Sigma1 selective ligand 
Isolation of Sigma1 and its associated proteins was done using the immobilized 
nickel NTA affinity purification method. LC/MS screening on the nickel purified Sigma1 
had revealed that Sigma1-HA-His associated with nearly eighty different proteins. 
However, the extent with which those interactions could potentially be modulated by 
Sigma1 selective ligands was still unknown. In order to answer these questions, the 
affinity purification technique was optimized to reveal as many of the associations as 
clearly as possible, while still removing most of the nonspecific binding on the resin. The 
lysis buffer we used to solubilize the cells was entirely non-ionic and turned out to be 
more suitable for these experiments as it had the enabled us to maintain the protein 
associations. The wash conditions, binding time, and imidazole concentrations were all 
considered as factors to optimize during the development of this protocol. In addition, a 
step-gradient of the concentration of the imidazole elution was used in order to allow for 
ideal accessibility of the histidine residues on the resin with each subsequent elution. 
Another issue that we had to consider was that some of the Sigma1 protein associations 
were labile, requiring us to minimize the freeze and thaw cycles and even incorporate the 
addition of a permeable, homobifunctional chemical crosslinker to covalently link 
Sigma1 to associated proteins within live cells.  
After taking all these steps into consideration, we were able to isolate Sigma1-
HA-His from the MDA-MB-468cells (Figure 1). Using this same protocol, VCP was 
pulled down along with Sigma1-HA-His as well (Figure 2). We then wanted determine 
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the overall changes to Sigma1 associations when these cells were treated with Sigma1 
ligand. We found that some proteins of higher molecular weight had a lower extent of 
association when treated with Sigma1 ligand (Figure 3). VCP was a protein that was 
shown to dissociate from Sigma1 when treated with the Sigma1 selective ligand (Figure 
4).  
Sigma1’s role in autophagy 
In order to study Sigma1’s role in autophagy, we examined the effects of Sigma1 
ligand on autophagy and found that it induced autophagosome formation (Figure 5). This 
led us to question whether it was possible to modulate the characteristics of other proteins 
involved in autophagy with the use of Sigma1 ligand, and also to see if these proteins 
colocalized within the autophagosomes. VCP, p62, and ubiquitin all co-localized with 
LC3 when treated with Sigma1 ligand (Figures 6-8), indicating that the sequestration of 
ubiquitnated proteins can be modulated by Sigma1. In addition, VCP’s colocalization 
into the autophagosomes when treated with Sigma1 ligand is further confirmation of an 
interdependent connection between Sigma1 and VCP. Although these results show the 
effects of the ligand, they do not give much insight into what is happening with 
Sigma1when treated with ligand. Sigma1 levels do not change as seen by Western blot, 
but the microscopy indicates that they are localized to different areas within the cells 
(Figure 9). This suggests that the ligand-mediated movement of Sigma1 could possibly 
result in the altered associations of Sigma1 with proteins such as VCP. It is possible that 
some of the downstream effects that we see with the ligand treatments occur (such as 
induction of ER stress, UPR and autophagosome formation) are a consequence of these 
altered associations. 
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We can see further confirmation of Sigma1’s role in autophagy by knocking down 
Sigma1and then treating the cells with Sigma1 ligand. There is a noted decrease in the in 
the levels of LC3 II in the Sigma1 siRNA lane when compared with the control, further 
indicating Sigma1’s role in autophagy. In addition, VCP siRNA also showed similar 
results, allowing us to further see the connection between Sigma1 and VCP (Figure 10).  
The levels of Sigma1 stay the same when treated with ligand. And when Sigma1 
is knocked down to nearly 60% of its basal levels using siRNA, the same trend is 
observed. However, there are even lower levels of Sigma1in cells that had the drug 
washed out 24 hours after initial treatment (Figure 11). To further prove this, we did 
subcellular fractionation to show that there indeed is a shift biochemically when these 
cells are treated with Sigma1ligand (Figure 12). We can clearly see a shift of VCP, p62, 
and ubiquitin into the autophagosomes when treated with Sigma1 ligand, again 
supporting the results observed with the immunofluorescence microscopy (Figures 6-8).  
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Chapter 4: Discussion 
 
Identifying a physical association between VCP and Sigma1 is gives insight into 
the one of the possible mechanisms of action of Sigma1 and its role in tumor cells. The 
dissociation of VCP from Sigma1 after treatment with the ligand suggests that the 
interaction between the two proteins is key for the maintenance of ER protein 
homeostasis, and not having it could be the driving force behind the effects of the ligand 
in which it induces activates the UPR and autophagy. However, what remains to be seen 
between the two proteins is whether their physical interaction is direct, as that could 
provide conclusive evidence of their interdependence as essential for the various 
downstream phenotypes. To answer this question, the samples can be fractionated and the 
proteins within the cells can be separated according to size, physical structure, and 
biochemistry. Following that, the individual fractions can then be affinity purified and 
examined on Western blot. If the dissociation between VCP and Sigma1 corresponds to 
the overall movement (from one fraction to another) of the individual protein, it can 
provide for proof that the association between the two is direct.  
The biochemical fractionation revealed the possible mechanism of action with 
which this ligand induced ER stress, UPR, and autophagy. And the Sigma1 siRNA 
experiments showed the clear effects of Sigma1 on ubiquitin selective autophagy. A 
minimum population of Sigma1 is required for these cells to survive, and knocking them 
down to below these levels results in cytotoxicity. To take this a step further, it would be 
interesting to see the result of fractionation experiments on Sigma1 siRNA as they would 
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reveal whether there is minimum vital population of Sigma1 that is required for these 
ligand-mediated effects.  
We propose that Sigma1 selective ligands provide for a way to specifically 
interfere with the cells intrinsic ER protein homeostasis and thus a novel approach to 
treating cancer. 
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  Chapter 5: Figures 
Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
Sigma1-HA-His pulldown using Ni-NTA. In this experiment, Sigma1-HA-His was pulled down 
from the Nickel beads without the use of a chemical crosslinker. In order to do this experiment, 
the MDA-MB-468 breast cancer cell lines were first stably transfected with dual, affinity 
purification tags and purified using the His tags. The samples were then run on a western blot and 
probed with the antibody for HA.  A). The control cell line for this experiment was the MDA468 
cell line that did not contain either of the aforementioned affinity purification tags.  B). Three of 
the Nickel purified elutions for each cell line are shown. 
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Figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
On the same gel as Figure 1, when probed with the antibody for VCP was identified and 
confirmed as a Sigma1-associating protein. A). Image depicting endogenous levels of VCP and 
also no changes in the levels of VCP in the cell line containing the affinity purification tags. B). 
The elution fractions that were purified using the NiNTA method.  
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Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effects of treatment with Sigma1 ligand. Without the addition of reducing agent DTT to 
denature the bonds prior to western blotting, it is possible to see the global differences with these 
protein associations when these cells are treated with Sigma1-antagonist. There are fewer high 
molecular weight proteins associating with Sigma1 when treated with Sigma1 ligand (Elution 1 
with ligand when compared with Elution1 in Control), while the levels of Sigma1 overall do not 
change.  
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Figure 4 
 
 
 
 
 
 
 
 
 
  
 
 
 
Effect of Sigma1 ligand on its association with VCP. A). VCP levels did not change with 
ligand treatment. B.) VCP association with Sigma1 decreased with ligand treatment. C). Four 
different replicates of this experiment allowed us to quantify this dissociation of VCP from 
Sigma1. The intensity of VCP was calculated relative to the levels of Sigma1 in each 
corresponding lane.  
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Figure 5 
 
 
 
 
 
 
Sigma1 ligand induces autophagosome formation.  Stably transfected MDA 468 GFP-LC3 
cells were treated with Sigm1 ligand for 24 hours. Immunofluorescence, confocal microscopy 
image of control and ligand treated cells are shown. The GFP concentrated punctae seen in the 
ligand treated cells are characteristic of autophagosome formation.  
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Figure 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VCP colocalizes with LC3 autophagosomes when treated with Sigma1 ligand. The DAPI 
stain stains genomic material, so the blue is representative of the nucleus. The green stain is 
representative of the LC3, and red for VCP. A merged image between the green and red should 
stain yellow, indicative of the colocalization between VCP and LC3. (Note: diameter of cells is 
~20µm) 
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Figure 7 
 
 
 
 
 
 
 
 
 
 
 
             
 
Ubiquitin colocalizes with LC3 autophagosomes when treated with Sigma1 ligand. The 
DAPI stain stains genomic material, so the blue is representative of the nucleus. The green stain is 
representative of the LC3, and red for Ubiquitin. A merged image between the green and red 
should stain yellow, indicative of the colocalization between Ubiquitin and LC3. (Note: diameter 
of cells is ~20µm) 
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Figure 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
p62 colocalizes with LC3 autophagosomes when treated with Sigma1 ligand. The DAPI stain 
stains genomic material, so the blue is representative of the nucleus. The green stain is 
representative of the LC3, and red for p62. A merged image between the green and red should 
stain yellow, indicative of the colocalization between p62 and LC3. (Note: diameter of cells is 
~20µm) 
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Figure 9 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sigma1 levels do not change when treated with ligand, but they are redistributed within the 
cells. A). A western blot of whole cell lysates showing Sigma1 levels staying the same even with 
ligand treatment for 16 hours. B). Similarly treated cells were stained with a Sigma1 antibody, 
and the microscopy indicated that there was a redistribution of Sigma1 to different locations 
within the cell when treated with the ligand.  
  
Control Sigma1 ligand 
Sigma1 staining 
A  B 
Control        Sigma1 
                       ligand 
Sigma1 
β-actin 
27 
 
Figure 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ubiquitin-selective autophagy is mediated by Sigma1 ligand. A). T47 D cells that were 
transfected with Sigma1 siRNA showed a decrease in LC3 II induction when compared with 
control siRNA that was also treated with the same concentration of Sigma1 ligand. In addition, 
the altered ubiquitin profile in those same lanes also suggests that Sigma1 plays a role in 
ubiquitin-selective autophagy. B). Similarly, there is a decrease in both the autophagosome 
formation and an altered ubiquitin profile in cells that had VCP knocked down, and then 
subsequently treated with Sigma1 ligand.  
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Figure 11 
 
Sigma1 knockdown in whole cell lysates. Again, we can see that there are similar levels of 
Sigma1 in cells when treated with Sigma1 ligand. However, in cells that have Sigma1 siRNA, 
there is a reduction of nearly 60% of total Sigma1. And when the cells are kept on the plate and 
drug is washed out, there are even lower amounts of Sigma1 left. 
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Figure 12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Biochemical subcellular fractionation. Treatment with Sigma1 ligand does not change Sigma1 
levels, but it does alter the distribution of Sigma1, and other proteins of interest within the cell. 
This experiment reveals that VCP, p62, and Ubiquitin all shift towards the fraction corresponding 
to the autophagosomes (indicated by the existence of the doublet in the samples treated with 
ligand). The quantifications represent the amount of the protein present in a particular fraction.  
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